Filter Results

Locations

Study status

(for at least one location)

Gender

Age

Healthy Volunteer

What is this?
A volunteer subject with no known significant health problems who participates in research to test a new drug, device or intervention. These volunteers are recruited to serve as controls for patient groups. Healthy volunteers receive the same test, procedure, or drug the patient group receives.

Study phase

What is this?
During the early phases (phases 1 and 2), researchers assess safety, side effects, optimal dosages and risks/benefits. In the later phase (phase 3), researchers study whether the treatment works better than the current standard therapy. They also compare the safety of the new treatment with that of current treatments. Phase 3 trials include large numbers of people to make sure that the result is valid. There are also less common very early (phase 0) and later (phase 4) phases. Phase 0 trials are small trials that help researchers decide if a new agent should be tested in a phase 1 trial. Phase 4 trials look at long-term safety and effectiveness, after a new treatment has been approved and is on the market.

Search Results 131-140 of 603 for hematology

Edit search filters
  1. CD19-Directed CAR-T Cell Therapy For The Treatment Of Relapsed/​Refractory B Cell Malignancies

    Rochester, MN

  2. A Study To Evaluate Daratumumab/rHuPh20 +/- Lenalidomide As Post-ASCT Maintenance For Multiple Myeloma With Minimal Residual Disease (MRD) To Direct Therapy Duration

    Scottsdale/Phoenix, AZ, Eau Claire, WI, Rochester, MN

  3. A Study To Evaluate The Safety And Effectiveness Of Metformin And Nelfinavir With Bortezomib In Patients With Relapsed And/or Refractory Multiple Myeloma

    Jacksonville, FL, Rochester, MN

  4. A Study Of Ovarian Tissue Freezing For The Preservation Of Fertility In Children

    Rochester, MN

  5. A Study To Evaluate The Long-Term Safety And Effectiveness Of Caplacizumab For Patients Who Completed Study ALX0681-C301

    Rochester, MN

  6. Belantamab, Lenalidomide, And Daratumumab For Newly-diagnosed Multiple Myeloma

    Rochester, MN

  7. A Study Of A New Way To Treat Children And Young Adults With A Brain Tumor Called NGGCT

    Rochester, MN

  8. A Study To Evaluate The Safety And Effectiveness Of ALLO-501A CAR T Cell Therapy In Adults With Relapsed/ Refractory Large B Cell Lymphoma

    Scottsdale/Phoenix, AZ

  9. The EMPrint™ Ablate And RESect Study In Patients With Metastatic Lung Tumors

    Rochester, MN

  10. A Study Combining Tofacitinib with Gemcitabine for the Treatment of Pancreas Cancer in Patients who are Losing Weight

    Rochester, MN

.

Mayo Clinic Footer